Business Wire

NY-CONDECO

Share
Employees Want the Best of Both Worlds: New Survey From Condeco Reveals Critical Facets of Hybrid Work That Business Leaders Need to Address

Condeco , a global leader in workspace scheduling software, is today announcing new research that reveals the importance of fostering a workplace that understands and respects employee needs, with hybrid work opportunities at its core. Its findings support the understanding that hybrid capabilities lead to greater employee advocacy and happiness at work and show that when it comes to recommending their company, hybrid workers can be the biggest advocates.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220412005267/en/

Allowing for a better work-life balance was identified as one of the biggest benefits of hybrid working through Condeco’s new research, which shows a direct relationship between employee satisfaction and improved mental and emotional well-being. Significantly, more than a third of workers surveyed reported that a hybrid work model has positively impacted their mental and physical health.

“Everyone wants something different out of work, but we can clearly see that almost no one wants to be back in the office full-time,” said Paul Statham, Condeco’s CEO & Founder. “We all know by now that hybrid models are key to ensuring a healthy work-life balance, but how each employer acts on that realization will determine their employees’ fulfillment with their company. No one is suggesting that the office is obsolete, on the contrary, it remains a vital place for employees to collaborate and engage. Business leaders looking to provide the best of both worlds for their employees must find a way to transform their offices from a place employees have to go to a place they want to go.”

“The need to have the right digital tools in place has emerged as one of the most important things to get right for hybrid working,” continued Lynda Lowe, CMO at Condeco. “But different generations have different definitions of what the ‘right tools’ are. This research clearly shows the biggest barriers to hybrid working and the fact that many employees still don’t feel that their company is using the right tools for hybrid working.”

Condeco polled 1,500 of today’s workers to get a pulse on the attitudes towards hybrid work and how these feelings are impacting businesses’ acclimation to the future of the working world. Key findings include:

Hybrid Workers Are Happy Workers – And in Turn, They’re Your Most Loyal Employees

  • 62% of respondents said they feel satisfied with their current hybrid work schedule – and fostering a work culture that brings happiness helps employers attract and retain top talent.
  • Hybrid workers are employers’ biggest advocates, with 63% saying they would recommend their company as an ideal work destination.
  • Nearly half of those back in their offices full-time would like to be more hybrid, which employers struggling with the ‘Great Resignation’ appear not to be considering.

Hybrid Work Has Had a Positive Impact on Mental Health, But There Is Still Room for Improvement

  • 34% of respondents feel that hybrid working has had a positive impact on their mental and physical health, with only 11% feeling that it has had a negative effect.
  • 69% of hybrid workers agreed that their employer takes into consideration the emotional and mental wellbeing of employees.
  • The number one benefit of hybrid working was a better work-life balance, with the lack of a social environment offered by work being the biggest barrier to remote working.

Tech Is the Backbone of Hybrid Work – Yet Only Half of Today’s Employees Have the Right Tools

  • Businesses have realized the opportunity of hybrid working – 78% of managers believe their business has been streamlined as a result and 80% trust their employees to get their work done.
  • Having the right digital tools was identified as the top need to ensuring hybrid working, but only 51% of employees agree that their company is using the right tools to support flexible work and only 50% of respondents feel their company is open to feedback about their digital tool stack.
  • Companies are grappling with how best to bring employees back to the office on a flexible basis. To ensure collaboration and high productivity, employers must consider their workplace tech as the backbone to their strategy.

As part of Condeco’s broader marketing campaign that addresses today’s cultural shift in business, Condeco is today releasing a new film short that shines light on the generational divide that has emerged out of the pandemic, and light-heartedly cements the importance of having an employer that understands and embraces employee needs. You can see the full broadcast here .

To download Condeco’s full survey, complete with additional statistics and methodology, please visit: https://www.condecosoftware.com/modern-workplace/research/attitudes-to-hybrid-working-report-2022/ .

About Condeco

Condeco is the global leader in enterprise level workspace solutions. Our software is designed to equip everyone with the tools they need for a seamless end to end experience in today’s office. By giving people control over flexible work, we deliver the certainty people need, enable the collaboration teams crave, and facilitate the insights on capacity that employers demand. From visitor management to workspace booking to office optimization, we are trusted by over 2000 of the world’s largest companies to realize their future at work.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 07:00:00 CEST | Press release

Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t

Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay18.9.2025 07:00:00 CEST | Press release

Cetaphil's new Skin Activator Hydrating & Firming Line harnesses a proprietary formula, co-created with dermatologists and offering targeted, high-performance skincare designed to improve the appearance of skin affected by dermatoporosis The line’s new Skin Activator technology uses microdosed alpha hydroxy acid (AHA) and encapsulated centella asiatica (CICA) to wake up sleeping surface skin cells To help bring this segment-defining product line to life, Cetaphil is partnering with acclaimed actress, director, and advocate, Mariska Hargitay, a powerful voice in embracing beauty at every stage Galderma today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is redefining daily skincare with its new Skin Activator Hydrating & Firming line. The launch marks an entirely new skincare segment of advanced hydration and firming solutions designed specifically for improving the appearance of aging, thinning, and fragile skin. As people age, surface

Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland18.9.2025 07:00:00 CEST | Press release

Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilienceMerck’s first climate-neutral manufacturing facility, powered by 100 percent renewable electricityNew Blarney site in Cork, Ireland expands filter manufacturing capacity, creating more than 200 jobs by 2028 Merck, a leading science and technology company, has opened today its €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland. The site is Merck’s first manufacturing facility designed for full climate-neutral operations, marking a key milestone in the company’s ambition to achieve climate neutrality by 2040. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917767425/en/ Merck's new Blarney site in Cork expands company's filter capacity, creating 200+ jobs by 2028 The 3,000-square-meter cleanroom facility supports global demand for critical filtration products used in the manufacturin

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)17.9.2025 21:46:00 CEST | Press release

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Commission (EC) has approved ROMVIMZA™ (vimseltinib) in the European Union (EU) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability1. “The European Commission’s approval of vimseltinib for TGCT is a significant milestone for Deciphera, ONO, and TGCT patients across the European Union who are in need of a non-invasive treatment option. We are excited to leverage our global commercial infrastructure to bring vimseltinib to these patients,” said Ryota Udagawa, President and Chief Executive Officer of Deciphera. “We look forward to worki

Northern Escape Heli-Skiing Sees Global Surge in Demand as Adventurers Seek Canada’s Legendary Powder17.9.2025 18:09:00 CEST | Press release

Luxury adventure travel continues accelerating, with analysts projecting ~7.6% annual growth through 2030 [1][5]. Meanwhile, global tourism reached record highs in 2024 [2], and ski tourism is above pre-pandemic norms [3]. Northern Escape Heli-Skiing (NEH), named World’s Best Heli-Ski Operator by the World Ski Awards [4] in 2022, 2023, and 2024, continues to welcome a truly international mix of guests each winter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909723150/en/ Global Appeal Post-pandemic travellers prioritize remote, nature-led adventures and privacy-forward itineraries [1][3]. Adventure tourism is on a sharp upswing globally [5], while research highlights how social media and influencer content accelerate demand for marquee mountain experiences [7]. At the same time, heli-sports are forecast to expand steadily across Canada, Europe, APAC, and South America [8]. World’s Best Heli-Ski NEH operates in BC’s Ske

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye